|
| 37419138 | Alcohol and drug use severity are independently associated with antiretroviral adherence in the current treatment era. | AIDS Care | 2024 |
| 38051788 | The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapy. | AIDS | 2024 |
| 36596305 | Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy. | Cell Host Microbe | 2023 |
| 36399783 | Vaporized Nicotine (E-Cigarette) and Tobacco Smoking Among People With HIV: Use Patterns and Associations With Depression and Panic Symptoms. | Journal of acquired immune deficiency syndromes (1999) | 2023 |
| 37650767 | African American/Black race, apolipoprotein L1 , and serum creatinine among persons with HIV. | AIDS | 2023 |
| 37869406 | Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus. | Open Forum Infect Dis | 2023 |
| 37461460 | Risk Stratification of Advanced Fibrosis in HIV Patients With Hepatic Steatosis Using the NAFLD Fibrosis and BARD Scores. | | 2023 |
| 37018921 | Plasma Interleukin-6 (IL-6), Angiopoietin-2, and C-Reactive Protein Levels Predict Subsequent Type 1 Myocardial Infarction in Persons With Treated HIV Infection. | J Acquir Immune Defic Syndr | 2023 |
| 36951656 | Impact of age, antiretroviral therapy, and cancer on epigenetic aging in people living with HIV. | Cancer Med | 2023 |
| 36883578 | Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study. | Clin Infect Dis | 2023 |
| 37011013 | Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection. | | 2023 |
| 36877848 | HIV post-treatment controllers have distinct immunological and virological features. | Proc Natl Acad Sci U S A | 2023 |
| 36935288 | Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial. | Vaccine | 2023 |
| 36541802 | Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment Control. | J Virol | 2023 |
| 36534786 | Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection. | Cancer Prev Res (Phila) | 2023 |
| 34878432 | Association of the VACS Index With Hospitalization Among People With HIV in the NA-ACCORD. | J Acquir Immune Defic Syndr | 2022 |
| 36159042 | Associations between female birth sex and risk of chronic kidney disease development among people with HIV in the USA: A longitudinal, multicentre, cohort study. | EClinicalMedicine | 2022 |
| 35743539 | Hepatitis B Virus and Tuberculosis Are Associated with Increased Noncommunicable Disease Risk among Treatment-Naïve People with HIV: Opportunities for Prevention, Early Detection and Management of Comorbidities in Sierra Leone. | Journal of Clinical Medicine | 2022 |
| 36332596 | Alcohol consumption upon direct-acting antiviral therapy for hepatitis C among persons with human immunodeficiency virus in the United States. | Drug Alcohol Depend | 2022 |
| 35796732 | Exploring definitions of retention in care for people living with HIV in the United States in the modern treatment era. | AIDS | 2022 |
| 35134850 | Current Antiretroviral Treatment Among People With Human Immunodeficiency Virus in the United States: Findings from the Centers for AIDS Research Network of Integrated Clinic Systems Cohort. | Clin Infect Dis | 2022 |
| 34704092 | Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020. | | 2021 |
| 34127579 | Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria. | AIDS | 2021 |
| 34170644 | B subgroup detection in a small hospital transfusion service. | Immunohematology | 2021 |
| 33898535 | Antiretroviral Drugs Regulate Epigenetic Modification of Cardiac Cells Through Modulation of H3K9 and H3K27 Acetylation. | Frontiers in Cardiovascular Medicine | 2021 |
| 34188039 | Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV. | Nat Commun | 2021 |
| 33002619 | Prevalence of hepatitis B surface antigen and serological markers of other endemic infections in HIV-infected children, adolescents and pregnant women in Sierra Leone: A cross-sectional study. | International Journal of Infectious Diseases | 2021 |
| 34404330 | Assessing eligibility for differentiated service delivery, HIV services utilization and virologic outcomes of adult HIV-infected patients in Sierra Leone: a pre-implementation analysis. | Global Health Action | 2021 |
| 34909782 | Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US. | medRxiv | 2021 |
| 34377726 | Care Facilitation Advances Movement Along the Hepatitis C Care Continuum for Persons With Human Immunodeficiency Virus, Hepatitis C, and Substance Use: A Randomized Clinical Trial (CTN-0064). | Open Forum Infect Dis | 2021 |
| 34888397 | A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy. | Open Forum Infect Dis | 2021 |
| 32675559 | Hepatitis C virus modulates IgG glycosylation in HIV co-infected antiretroviral therapy suppressed individuals. | AIDS | 2020 |
| 32300019 | A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption. | Proceedings of the National Academy of Sciences of the United States of America | 2020 |
| 31253727 | NK Response Correlates with HIV Decrease in Pegylated IFN-α2a-Treated Antiretroviral Therapy-Suppressed Subjects. | J Immunol | 2019 |
| 31745112 | Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients. | Sci Rep | 2019 |
| 31583331 | Four Weeks of Treatment With Rifaximin Fails to Significantly Alter Microbial Diversity in Rectal Samples of HIV-Infected Immune Non-Responders (ACTG A5286) Which May be Attributed to Rectal Swab Use. | Pathogens and Immunity | 2019 |
| 29920584 | The North-South Divide: Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized Human Immunodeficiency Virus-Infected Patients in 11 US Cities. | Clin Infect Dis | 2019 |
| 30809901 | Pharmacokinetic stability of macrocyclic peptide triazole HIV-1 inactivators alone and in liposomes. | Journal of Peptide Science | 2019 |
| 31437485 | Investigating the distribution of HIV-1 Tat lengths present in the Drexel Medicine CARES cohort. | Virus Res | 2019 |
| 31266936 | Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice. | Nature Communications | 2019 |
| 29771277 | Effect of Antiretroviral Therapy on Plasma Concentrations of Chloroquine and Desethyl-chloroquine. | Clinical Infectious Diseases | 2018 |
| 30024859 | HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers. | J Clin Invest | 2018 |
| 30548022 | Toward the Cure of HIV-1 Infection: Lessons Learned and Yet to be Learned as New Strategies are Developed. | AIDS Reviews | 2018 |
| 29968495 | Broad-Spectrum and Personalized Guide RNAs for CRISPR/Cas9 HIV-1 Therapeutics. | AIDS Res Hum Retroviruses | 2018 |
| 30195766 | Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice. | Molecular Therapy - Nucleic Acids | 2018 |
| 30085241 | The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. | J Infect Dis | 2018 |
| 29746266 | Ibalizumab. | | 2018 |
| 29593048 | Effect of Short-Term Antiretroviral Therapy Interruption on Levels of Integrated HIV DNA. | J Virol | 2018 |
| 28210784 | Novel AIDS therapies based on gene editing. | Cellular and Molecular Life Sciences | 2017 |
| 28419653 | HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects. | J Viral Hepat | 2017 |